Interferons in relapsing remitting multiple sclerosis

Lancet. 2003 May 24;361(9371):1822; author reply 1823-4. doi: 10.1016/S0140-6736(03)13418-6.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic*
  • Data Interpretation, Statistical
  • Humans
  • Interferon-alpha / therapeutic use
  • Interferon-beta / therapeutic use*
  • Magnetic Resonance Imaging
  • Meta-Analysis as Topic
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Patient Compliance
  • Research Design
  • Treatment Outcome

Substances

  • Interferon-alpha
  • Interferon-beta